Continuing effectiveness of serogroup a meningococcal conjugate vaccine, Chad, 2013

Hdl Handle:
http://hdl.handle.net/10144/338935
Title:
Continuing effectiveness of serogroup a meningococcal conjugate vaccine, Chad, 2013
Authors:
Gamougam, Kadidja; Daugla, Doumagoum M; Toralta, Jacques; Ngadoua, Cyriaque; Fermon, Florence; Page, Anne-Laure; Djingarey, Mamoudou H; Caugant, Dominique A; Manigart, Olivier; Trotter, Caroline L; Stuart, James M; Greenwood, Brian M
Journal:
Emerging Infectious Diseases
Abstract:
In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated areas, but an epidemic continued in the rest of Chad. In 2012, the remaining Chad population was vaccinated, and the epidemic was halted.
Publisher:
Center for Disease Control
Issue Date:
1-Jan-2015
URI:
http://hdl.handle.net/10144/338935
DOI:
10.3201/eid2101.140256
PubMed ID:
25536336
Language:
en
ISSN:
1080-6059
Appears in Collections:
Vaccination

Full metadata record

DC FieldValue Language
dc.contributor.authorGamougam, Kadidjaen_GB
dc.contributor.authorDaugla, Doumagoum Men_GB
dc.contributor.authorToralta, Jacquesen_GB
dc.contributor.authorNgadoua, Cyriaqueen_GB
dc.contributor.authorFermon, Florenceen_GB
dc.contributor.authorPage, Anne-Laureen_GB
dc.contributor.authorDjingarey, Mamoudou Hen_GB
dc.contributor.authorCaugant, Dominique Aen_GB
dc.contributor.authorManigart, Olivieren_GB
dc.contributor.authorTrotter, Caroline Len_GB
dc.contributor.authorStuart, James Men_GB
dc.contributor.authorGreenwood, Brian Men_GB
dc.date.accessioned2015-01-27T17:50:10Z-
dc.date.available2015-01-27T17:50:10Z-
dc.date.issued2015-01-01-
dc.identifier.citationContinuing effectiveness of serogroup a meningococcal conjugate vaccine, chad, 2013. 2015, 21 (1):115-8 Emerging Infect. Dis.en_GB
dc.identifier.issn1080-6059-
dc.identifier.pmid25536336-
dc.identifier.doi10.3201/eid2101.140256-
dc.identifier.urihttp://hdl.handle.net/10144/338935-
dc.description.abstractIn 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated areas, but an epidemic continued in the rest of Chad. In 2012, the remaining Chad population was vaccinated, and the epidemic was halted.en_GB
dc.language.isoenen
dc.publisherCenter for Disease Controlen_GB
dc.rightsPublished by Centers for Disease Control (CDC) Archived on this site by permission of CDC, [url]http://www.cdc.gov/ncidod/eid[/url]en_GB
dc.titleContinuing effectiveness of serogroup a meningococcal conjugate vaccine, Chad, 2013en
dc.identifier.journalEmerging Infectious Diseasesen_GB

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.